These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28872273)

  • 41. Twelve months antiretroviral therapy retention among clients newly enrolled to care and treatment services in Geita Regin, Tanzania: does universal test and treat matter?
    Masuke R; Kihaga Y; Mashala M; Ndalio S; Sukari O; Panga O
    Pan Afr Med J; 2023; 46():20. PubMed ID: 38035160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Initiation of Antiretroviral Therapy During Acute HIV-1 Infection Leads to a High Rate of Nonreactive HIV Serology.
    de Souza MS; Pinyakorn S; Akapirat S; Pattanachaiwit S; Fletcher JL; Chomchey N; Kroon ED; Ubolyam S; Michael NL; Robb ML; Phanuphak P; Kim JH; Phanuphak N; Ananworanich J;
    Clin Infect Dis; 2016 Aug; 63(4):555-61. PubMed ID: 27317797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lessons learned from the PMTCT program in Swaziland: challenges with accepting lifelong ART for pregnant and lactating women - a qualitative study.
    Katirayi L; Chouraya C; Kudiabor K; Mahdi MA; Kieffer MP; Moland KM; Tylleskar T
    BMC Public Health; 2016 Oct; 16(1):1119. PubMed ID: 27776495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV viral suppression in TREAT Asia HIV Observational Database enrolled adults on antiretroviral therapy at the Social Health Clinic, the National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
    Boettiger DC; Khol V; Durier N; Law M; Sun LP
    Antivir Ther; 2016; 21(8):725-730. PubMed ID: 27124891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia.
    Wright ST; Law MG; Cooper DA; Keen P; McDonald A; Middleton M; Woolley I; Kelly M; Petoumenos K;
    J Int AIDS Soc; 2015; 18(1):19463. PubMed ID: 25865372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: multilevel analysis.
    Gezie LD
    BMC Res Notes; 2016 Jul; 9():377. PubMed ID: 27475982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dried blood spots for viral load monitoring in Malawi: feasible and effective.
    Rutstein SE; Hosseinipour MC; Kamwendo D; Soko A; Mkandawire M; Biddle AK; Miller WC; Weinberger M; Wheeler SB; Sarr A; Gupta S; Chimbwandira F; Mwenda R; Kamiza S; Hoffman I; Mataya R
    PLoS One; 2015; 10(4):e0124748. PubMed ID: 25898365
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved survival in HIV treatment programmes in Asia.
    De La Mata NL; Kumarasamy N; Khol V; Ng OT; Van Nguyen K; Merati TP; Pham TT; Lee MP; Durier N; Law M
    Antivir Ther; 2016; 21(6):517-527. PubMed ID: 26961354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Timeliness of Human Immunodeficiency Virus Diagnosis and Antiretroviral Treatment Initiation in the Era of Universal Testing and Treatment.
    Robertson MM; Braunstein SL; Hoover DR; Li S; Nash D
    J Infect Dis; 2019 Jul; 220(4):648-656. PubMed ID: 30997508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implementation of the Treat All Policy Among Persons with HIV Infection Enrolled in Care But Not on Antiretroviral Therapy - India, May 2017-June 2018.
    Mitruka K; Bamrotiya M; Agarwal R; Parvez A; Allam RR; Sivalenka S; Deoraj P; Prasad R; Devi U; Keskar P; Acharya S; Kannan P; Ganti R; Shah M; Todmal S; Kumar P; Chava N; Rao A; Tanwar S; Nyendak M; Ellerbrock T; Holtz TH; Gupta RS
    MMWR Morb Mortal Wkly Rep; 2018 Nov; 67(47):1305-1309. PubMed ID: 31199351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya.
    Odeny TA; DeCenso B; Dansereau E; Gasasira A; Kisia C; Njuguna P; Haakenstad A; Gakidou E; Duber HC
    J Int AIDS Soc; 2015; 18(1):20019. PubMed ID: 26507824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression.
    Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA
    AIDS Res Hum Retroviruses; 2009 Jun; 25(6):756-76. PubMed ID: 19500017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implementation of "Treat-all" at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey.
    Brazier E; Maruri F; Duda SN; Tymejczyk O; Wester CW; Somi G; Ross J; Freeman A; Cornell M; Poda A; Musick BS; Zhang F; Althoff KN; Mugglin C; Kimmel AD; Yotebieng M; Nash D;
    J Int AIDS Soc; 2019 Jul; 22(7):e25331. PubMed ID: 31623428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Between HIV diagnosis and initiation of antiretroviral therapy: assessing the effectiveness of care for people living with HIV in the public primary care service in Cape Town, South Africa.
    Scott V; Zweigenthal V; Jennings K
    Trop Med Int Health; 2011 Nov; 16(11):1384-91. PubMed ID: 21771213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
    J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on First line antiretroviral therapy in Mwanza, North-western Tanzania.
    Gunda DW; Kidenya BR; Mshana SE; Kilonzo SB; Mpondo BC
    BMC Res Notes; 2017 Jan; 10(1):45. PubMed ID: 28095920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiretroviral therapy initiation within seven days of enrolment: outcomes and time to undetectable viral load among children at an urban HIV clinic in Uganda.
    Ssebunya R; Wanyenze RK; Lukolyo H; Mutto M; Kisitu G; Amuge P; Maganda A; Kekitiinwa A
    BMC Infect Dis; 2017 Jun; 17(1):439. PubMed ID: 28629459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.